Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

M.D., '63 director of the Program on Global Public Health and the Common Good and the Boston College Global Observatory on Planetary Health, is the lead author of a groundbreaking new report about the ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Canaccord Genuity maintained its Buy rating on Boston Scientific (NYSE:BSX) shares and increased the price target to $117 from $101. The adjustment follows the company's robust fourth-quarter earnings ...

Climbing sales for a made-in-Minnesota system treating atrial fibrillation helped sustain Boston Scientific’s streak of bullish results as the company brushed off tariffs. The medtech company’s pulse ...

CDC orders pull back to comply with Trump executive orders Agency directive to divisions comes after initial guidance to review communications Editors of scientific journals question the legality ...

The scope of this survey covers establishments or enterprises that produce manufactured goods and mineral products (including processed products) set forth by the ministerial ordinance. Survey items ...

Porzingis swatted a season-high five shots, two shy of his career-best mark (7). Boston's center is having a tremendous season, as he's on pace to return second-round value in nine-category ...

Looking for a fun activity near you? Find live music, local markets, theatre productions, museum gallery conversations, and more with the interactive map below. The default view will show all ...